Intravenous ketamine for CRPS: Making too much of too little?

Pain

Volumn 150, Issue 1, 2010, Pages 10-11

  Bell, R F ^a   Moore, R A ^b  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLONIDINE; KETAMINE; MIDAZOLAM; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PLACEBO;

CLINICAL PRACTICE; CLINICAL TRIAL; COMPLEX REGIONAL PAIN SYNDROME; DRUG EFFICACY; DRUG INFUSION; DRUG SAFETY; EDITORIAL; HEALTH CARE COST; HUMAN; NONHUMAN; OUTPATIENT; PRIORITY JOURNAL;

ANALGESICS; COMPLEX REGIONAL PAIN SYNDROMES; HUMANS; INJECTIONS, INTRAVENOUS; KETAMINE;

EID: 77953122128     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pain.2010.03.014     Document Type: Editorial

References (13)

1. Curran H.V., and Monaghan L. In and out of the K hole: a comparison of the acute and residual effects of ketamine in frequent and infrequent ketamine users. Addiction 96 (2001) 749-760
2. Finch P.M., Knudsen L., and Drummond P.D. Reduction of allodynia in patients with complex regional pain syndrome: a double-blind placebo-controlled trial of topical ketamine. Pain 146 (2009) 18-25
3. Hsu E.S. Practical management of complex regional pain syndrome. Am J Ther 16 (2009) 147-154
4. Ioannides J.P.A. Contradicted and initially stronger effects in highly cited clinical research. JAMA 294 (2005) 218-228
5. Ioannides J.P.A. Why most published research findings are false. PLoS Med 2 (2005) e124
6. Jadad A.R., Moore R.A., Carroll D., Jenkinson C., Reynolds D.J., Gavaghan D.J., and McQuay H.J. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Control Clin Trials 17 (1996) 1-12
7. Kiefer R.T., Rohr P., Ploppa A., Dieterich H.J., Grothusen J., Koffler S., Altemeyer K.H., Unertl K., and Schwartzman R.J. Efficacy of ketamine in anesthetic dosage for the treatment of refractory complex regional pain syndrome: an open-label phase II study. Pain Med 9 (2008) 1173-1201
8. Narendran R., Frankle W.G., Keefe R., Gil R., Martinez D., Slifstein M., Kegeles L.S., Talbot P.S., Huang Y., Hwang D.R., Khenissi L., Cooper T.B., Laruelle M., and Abi-Dargham A. Altered prefrontal dopaminergic function in chronic recreational ketamine users. Am J Psychiatry 162 (2005) 2352-2359
9. Schwartzman R.J., Alexander G.M., Grothusen J.R., Paylor T., Reichenberger E., and Perreault M. Outpatient intravenous ketamine for the treatment of complex regional pain syndrome: a double-blind placebo controlled study. Pain 147 (2009) 107-115
10. Sigtermans M.J., van Hilten J.J., Bauer M.C., Arbous M.S., Marinus J., Sarton E.Y., et al. Ketamine produces effective and long-term pain relief in patients with Complex Regional Pain Syndrome Type 1. Pain 145 (2009) 304-311
11. Smith L.A., Oldman A.D., McQuay H.J., and Moore R.A. Teasing apart quality and validity in systematic reviews: an example from acupuncture trials in chronic neck and back pain. Pain 86 (2000) 119-132
12. Souzdalnitski D., Vadivelu N., and Chung K.S. Low-dose ketamine as an adjunct to routine pain practice. Are we ready yet?. Pain Pract 9 (2009) 405-406
13. Trujillo K.A., Zamora J.J., and Warmoth K.P. Increased response to ketamine following treatment at long intervals: implications for intermittent use. Biol Psychiatry 63 (2008) 178-183